ReviewFrontiers in cellular and infection microbiology2025
The strategies and mechanisms of enteroviruses to evade innate immunity and the vaccine progress of enteroviruses.
Review in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Complete genome sequencing and molecular characterization of indigenous enterovirus A71 genogroups D and G of India.Virology journal · 2026Article
- Toll-like receptors in infectious myocarditis: pathogen-specific recognition, spatiotemporal dynamic regulation and clinical translation.Frontiers in cardiovascular medicine · 2026Review
- MicroRNAs orchestrating host and vector-borne protozoan interactions: bridging immune modulation and cross-species communication.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enteroviruses (EVs) are a group of highly contagious RNA viruses that can cause a wide range of diseases, from mild infections to severe complications like neurological disorders and myocarditis. This review focuses on the innate immune evasion strategies employed by EVs, highlighting their mechanisms and consequences. EVs evade host immune responses through various tactics, including inhibiting pathogen recognition receptors (PRRs) such as toll-like receptors (TLRs) and RIG-I-like receptors (RLRs), disrupting key signaling pathways like nuclear factor kappa-B (NF-κB) and (JAK)-signal transducers and activators of transcription (STAT), and directly targeting interferon (IFN) signaling components. Specific viral proteases, such as 2A protease (2A
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.